Compare · ELV vs TRUP
ELV vs TRUP
Side-by-side comparison of Elevance Health Inc. (ELV) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.92B, about 69.5x TRUP ($1.16B).
- Over the past year, ELV is up 34.6% and TRUP is down 47.8% - ELV leads by 82.4 points.
- ELV has been more active in the news (9 items in the past 4 weeks vs 4 for TRUP).
- ELV has more recent analyst coverage (23 ratings vs 12 for TRUP).
- Company
- Elevance Health Inc.
- Trupanion Inc.
- Price
- $372.94+0.02%
- $26.71+1.44%
- Market cap
- $80.92B
- $1.16B
- 1M return
- -6.26%
- +9.42%
- 1Y return
- +34.64%
- -47.79%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 9
- 4
- Recent ratings
- 23
- 12
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest TRUP
- Trupanion Announces Second Quarter 2026 Earnings Release and Conference Call
- Chief Operating Officer Gallagher John R sold $10,926 worth of shares (431 units at $25.35) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 32,634 units (SEC Form 4)
- SEC Form 144 filed by Trupanion Inc.
- Trupanion to Participate in Virtual Fireside Chat with Piper Sandler
- Trupanion Announces Winners of the 2026 Veterinary Appreciation Day® Awards
- Trupanion Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- EVP, North Am & Vet Strategy Weinrauch Steve exercised 8,500 shares at a strike of $15.46 and sold $146,828 worth of shares (6,674 units at $22.00), increasing direct ownership by 2% to 78,062 units (SEC Form 4)
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Chief Operating Officer Gallagher John R sold $78,153 worth of shares (3,603 units at $21.69) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 33,065 units (SEC Form 4)